The role of the immune system in myelodysplasia: implications for therapy

Seminars in Hematology
Elaine M Sloand, Katayoun Rezvani

Abstract

Patients with myelodysplastic syndrome (MDS) have intrinsic, usually acquired genetic defects in their hematopoietic stem cells, but some others exhibit T-cell-mediated inhibition of hematopoiesis and good responses to immunosuppression. In these cases, MDS shares a similar pathophysiology with aplastic anemia (AA). Here, we review the evidence supporting a role of the immune system in the pathophysiology of MDS and the results of clinical trials of immunosuppressive agents.

References

Nov 1, 1981·Hoppe-Seyler's Zeitschrift für physiologische Chemie·W Jilg, K Hannig
Dec 24, 1997·British Journal of Haematology·J J MolldremA J Barrett
Jun 3, 1998·British Journal of Haematology·J E Parker, G J Mufti
Aug 26, 1998·Leukemia & Lymphoma·P LepelleyP Fenaux
Dec 22, 1999·Oncogene·M Barkett, T D Gilmore
Jun 28, 2001·Leukemia & Lymphoma·J E Parker, G J Mufti
Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
Aug 6, 2002·Annals of Internal Medicine·Jeffrey J MolldremA John Barrett
Aug 16, 2002·Clinical and Laboratory Haematology·W AtoyebiT J Littlewood
Feb 18, 2003·British Journal of Haematology·Sally B KillickJudith C W Marsh
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniela CilloniUNKNOWN Piedmont Study Group on Myleodysplastic Syndromes
May 29, 2003·Leukemia & Lymphoma·Takashi Shimamoto, Kazuma Ohyashiki
Jul 12, 2003·Journal of Cancer Research and Clinical Oncology·Toshiki YamadaHisataka Moriwaki

❮ Previous
Next ❯

Citations

Oct 16, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Mar TormoMarisa Calabuig
May 27, 2009·Current Opinion in Hematology·Raphael Itzykson, Pierre Fenaux
Jul 10, 2010·Drugs·Jeffrey BryanHagop Kantarjian
Jul 17, 2009·American Journal of Clinical Pathology·Attilio Orazi, Magdalena B Czader
Mar 5, 2016·International Journal of Hematology·Daisuke Hasegawa
Jan 15, 2009·Journal of Internal Medicine·M Jädersten, E Hellström-Lindberg
Sep 10, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L R SullivanS B Mossad
Oct 2, 2009·British Journal of Haematology·Fiorella AlfinitoGiuseppe Terrazzano
Jun 24, 2008·Expert Opinion on Pharmacotherapy·Sridhar Srinivasan, Charles A Schiffer
Sep 21, 2010·La Revue de médecine interne·O FainP Fenaux
Feb 11, 2015·Cellular and Molecular Life Sciences : CMLS·Lili YangSheng Wei
Nov 7, 2013·Advances in Hematology·Ethan A Natelson, David Pyatt
Jun 18, 2016·International Journal of Molecular Sciences·Andreas GlenthøjKirsten Grønbæk
Aug 5, 2016·Frontiers in Oncology·Claude LambertCarmen Aanei
Aug 4, 2016·Expert Opinion on Emerging Drugs·Amer M ZeidanRami Komrokji
Oct 22, 2011·The Korean journal of laboratory medicine·Hee-Won MoonMark Hong Lee
Jun 24, 2018·Current Hematologic Malignancy Reports·Kathryn S Ivy, P Brent Ferrell
Dec 7, 2018·Advances in Hematology·Nora ChokrSamer Chokr

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis